{"transactions":[{"id":4188181,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":172562,"kind":"organization","name":"MPM BIOVENTURES V, L.P.","position":1,"cik":"0001482716","reported_name":"MPM BIOVENTURES V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":2480,"kind":"person","name":"EVNIN LUKE","position":2,"cik":"0001134657","reported_name":"EVNIN LUKE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":2481,"kind":"person","name":"GADICKE ANSBERT","position":3,"cik":"0001134655","reported_name":"GADICKE ANSBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172563,"kind":"organization","name":"MPM ASSET MANAGEMENT INVESTORS BV5 LLC","position":4,"cik":"0001541412","reported_name":"MPM ASSET MANAGEMENT INVESTORS BV5 LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172564,"kind":"organization","name":"MPM BIOVENTURES V GP LLC","position":5,"cik":"0001482714","reported_name":"MPM BIOVENTURES V GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172565,"kind":"organization","name":"MPM BIOVENTURES V LLC","position":6,"cik":"0001482715","reported_name":"MPM BIOVENTURES V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Junior Preferred Stock","published_at":"2017-10-11T18:25:17.000Z","date":"2017-10-10","kind":"exercise","acquired":false,"shares":15887703,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock converted into approximately 0.10905125 shares of common stock upon the closing of the issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock converted into approximately 0.10905125 shares of common stock upon the closing of the issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock converted into approximately 0.10905125 shares of common stock upon the closing of the issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares of Series A-1 Junior Preferred Stock were held as follows: 15,293,569 by BV V  and 594,134 by AM BV5."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1732573},"source":{"system":"sec-edgar","filing":"0001209191-17-056612","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1134655/000120919117056612/doc4.xml","form_type":"4"}},{"id":4188180,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":172562,"kind":"organization","name":"MPM BIOVENTURES V, L.P.","position":1,"cik":"0001482716","reported_name":"MPM BIOVENTURES V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":2480,"kind":"person","name":"EVNIN LUKE","position":2,"cik":"0001134657","reported_name":"EVNIN LUKE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":2481,"kind":"person","name":"GADICKE ANSBERT","position":3,"cik":"0001134655","reported_name":"GADICKE ANSBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172563,"kind":"organization","name":"MPM ASSET MANAGEMENT INVESTORS BV5 LLC","position":4,"cik":"0001541412","reported_name":"MPM ASSET MANAGEMENT INVESTORS BV5 LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172564,"kind":"organization","name":"MPM BIOVENTURES V GP LLC","position":5,"cik":"0001482714","reported_name":"MPM BIOVENTURES V GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172565,"kind":"organization","name":"MPM BIOVENTURES V LLC","position":6,"cik":"0001482715","reported_name":"MPM BIOVENTURES V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2017-10-11T18:25:17.000Z","date":"2017-10-10","kind":"exercise","acquired":false,"shares":7651831,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock converted into approximately 0.10905125 shares of common stock upon the closing of the issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock converted into approximately 0.10905125 shares of common stock upon the closing of the issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock converted into approximately 0.10905125 shares of common stock upon the closing of the issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares of Series A Preferred Stock were held as follows: 7,365,688 by BV V  and 286,143 by AM BV5."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":834441},"source":{"system":"sec-edgar","filing":"0001209191-17-056612","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1134655/000120919117056612/doc4.xml","form_type":"4"}},{"id":4188179,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":172562,"kind":"organization","name":"MPM BIOVENTURES V, L.P.","position":1,"cik":"0001482716","reported_name":"MPM BIOVENTURES V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":2480,"kind":"person","name":"EVNIN LUKE","position":2,"cik":"0001134657","reported_name":"EVNIN LUKE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":2481,"kind":"person","name":"GADICKE ANSBERT","position":3,"cik":"0001134655","reported_name":"GADICKE ANSBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172563,"kind":"organization","name":"MPM ASSET MANAGEMENT INVESTORS BV5 LLC","position":4,"cik":"0001541412","reported_name":"MPM ASSET MANAGEMENT INVESTORS BV5 LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172564,"kind":"organization","name":"MPM BIOVENTURES V GP LLC","position":5,"cik":"0001482714","reported_name":"MPM BIOVENTURES V GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172565,"kind":"organization","name":"MPM BIOVENTURES V LLC","position":6,"cik":"0001482715","reported_name":"MPM BIOVENTURES V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-10-11T18:25:17.000Z","date":"2017-10-10","kind":"purchase","acquired":true,"shares":100000,"price":17,"value":1700000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares were purchased as follows: 96,260 by BV V and 3,740 by AM BV5."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares are held as follows: 2,595,559 by BV V and 100,833 by AM BV5.  Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein."}],"balance_after":2696392,"source":{"system":"sec-edgar","filing":"0001209191-17-056612","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1134655/000120919117056612/doc4.xml","form_type":"4"}},{"id":4188178,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":172562,"kind":"organization","name":"MPM BIOVENTURES V, L.P.","position":1,"cik":"0001482716","reported_name":"MPM BIOVENTURES V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":2480,"kind":"person","name":"EVNIN LUKE","position":2,"cik":"0001134657","reported_name":"EVNIN LUKE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":2481,"kind":"person","name":"GADICKE ANSBERT","position":3,"cik":"0001134655","reported_name":"GADICKE ANSBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172563,"kind":"organization","name":"MPM ASSET MANAGEMENT INVESTORS BV5 LLC","position":4,"cik":"0001541412","reported_name":"MPM ASSET MANAGEMENT INVESTORS BV5 LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172564,"kind":"organization","name":"MPM BIOVENTURES V GP LLC","position":5,"cik":"0001482714","reported_name":"MPM BIOVENTURES V GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":172565,"kind":"organization","name":"MPM BIOVENTURES V LLC","position":6,"cik":"0001482715","reported_name":"MPM BIOVENTURES V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-10-11T18:25:17.000Z","date":"2017-10-10","kind":"exercise","acquired":true,"shares":2567014,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock converted into approximately 0.10905125 shares of common stock upon the closing of the issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held as follows: 2,499,299 by MPM BioVentures V, L.P. (\"BV V\") and 97,093 by MPM Asset Management Investors BV5 LLC (\"AM BV5\"). MPM BioVentures V GP LLC and MPM BioVentures V LLC (\"BV LLC\") are the direct and indirect general partners of BV V and BV LLC is the manager of AM BV5. Ansbert Gadicke, Luke Evnin and Todd Foley are the members of BV LLC. Mr. Foley is a director of the Issuer and has separately filed a Form 4. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein."}],"balance_after":2596392,"source":{"system":"sec-edgar","filing":"0001209191-17-056612","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134655/000120919117056612/doc4.xml","form_type":"4"}}]}